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ABSTRACT
The human gut hosts trillions of microorganisms that exert a profound influence on human
biology. Gut bacteria communicate with their host by secreting small molecules that can signal
to distant organs in the body. Bile acids are one class of these signaling molecules, synthesized by
the host and chemically transformed by the gut microbiota. Among bile acid metabolizers, bile
acid 7-dehydroxylating bacteria are commensals of particular importance as they carry out the
7-dehydroxylation of liver-derived primary bile acids to 7-dehydroxylated bile acids. The latter
represents a major fraction of the secondary bile acid pool. The microbiology of this group of gut
microorganisms is understudied and warrants more attention. Here, we detail the bile acid
transformations carried out by the 7-dehydroxylating bacterium Clostridium scindens in vitro and
in vivo. In vitro, C. scindens exhibits not only 7α-dehydroxylating capabilities but also, the ability to
oxidize other hydroxyl groups and reduce ketone groups in primary and secondary bile acids. This
study revealed 12-oxolithocholic acid as a major transient product in the 7α-dehydroxylation of
cholic acid. Furthermore, the in vivo study included complementing a gnotobiotic mouse line
(devoid of the ability to 7-dehydroxylate bile acids) with C. scindens and investigating its coloniza-
tion dynamics and bile acid transformations. Using NanoSIMS (Nanoscale Secondary Ion Mass
Spectrometry), we demonstrate that the large intestine constitutes a niche for C. scindens, where it
efficiently 7-dehydroxylates cholic acid to deoxycholic acid. Overall, this work reveals a novel
transient species during 7-dehydroxylation as well as provides direct evidence for the colonization
and growth of 7-dehydroxylating bacteria in the large intestine.
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Introduction
Bile acids (BAs) are endogenous molecules synthe-
sized from cholesterol in the liver and stored in the
gall bladder. Upon meal stimulation, they are
released into the duodenum to facilitate the solu-
bilization and absorption of lipids and lipid-
soluble vitamins.1 A major fraction of the BA
pool (> 95%), actively reabsorbed in the terminal
ileum and passively along the entire intestinal
tract, returns to the liver through the hepatic por-
tal vein. Only a small proportion of the BA pool
(5%) enters the large intestine. This cycle is
referred to as the enterohepatic circulation of
BAs and occurs several times per day. During the
cycle, a small fraction of BAs escapes hepatic
uptake and reaches the systemic circulation.
Bile acids act as signaling molecules and are
thought to play a key role in the maintenance of
the host’s health. In addition to their local action in
the intestine, they are proposed to reach other organs
in the human body (via the systemic circulation).2
Bile acid receptors are found on many organs and
tissues (e.g., liver, pancreas, intestine, brown adipose
tissue), as well as on immune cells, suggesting the
broad field of action of these compounds.3 Bile acids
also act indirectly when they activate receptors that
induce the release of other signaling molecules. For
instance, the activation of the BA receptor Takeda
G-protein receptor 5 (TGR5) induces Glucagon-Like
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Peptide-1 (GLP-1) production by entero-endocrine
L-cells, which subsequently potentiates β-cell glu-
cose-induced insulin secretion in the pancreas.4
In the human intestinal tract, the two liver-
derived primary BAs (Figure 1), conjugated cho-
lic acid (CA) and chenodeoxycholic acid
(CDCA), undergo several transformations
mediated by gut microbes, leading to a large
diversity of secondary bile acids. The microbial
transformation of BAs in the gut is critical to BA-
mediated signaling as it modifies their affinity for
specific BA receptors.5 Bile acid 7-dehydroxylat-
ing bacteria are a group of gut commensals of
particular importance as they catalyze the dehy-
droxylation of liver-derived (primary) BAs at the
C7 position (i.e., 7-dehydroxylation) and produce
7-dehydroxylated BAs, which represent a large
fraction of the secondary BA pool in the large
intestine. Bile acids transformed by these bacteria
are agonists for TGR5, which is involved in the
regulation of metabolism and energy expenditure
as well as inflammation.6 In addition, BAs lacking
the 7-hydroxyl group are also associated with
protection from infection by a specific intestinal
pathogen, Clostridium difficile.7
The microbial transformations undergone by
BAs in the gut play an important role in health5,
and modulation of the bile acid pool composition
represents a promising avenue for the prevention
and treatment of various diseases.8 Perturbation of
the bile acid pool is linked to major metabolic
diseases (e.g., obesity, type 2 diabetes, non-
alcoholic fatty liver disease)9, cardiovascular dis-
eases (e.g., atherosclerosis)9, inflammatory diseases
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Figure 1. Structures of selected human and murine bile acids. Bile acids differ by the position of the hydroxyl groups on the
molecule. CA and CDCA are found both in humans and rodents, while UDCA and the muricholic acids are primary BAs synthesized
only in rodents. In humans, UDCA is produced from CDCA by microbial enzymes and therefore, is considered as a secondary bile
acid. The full list of BAs considered in this study and their structures is included in supplemental information (Table S1).
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(e.g., inflammatory bowel disease), gastrointestinal
cancers10, as well as Clostridium difficile infection.7
Collectively, these diseases exact a heavy socio-
economic toll due to their increasing occurrence
and severity in first-world countries. Bile acid
metabolizing bacteria, particularly 7-dehydroxylat-
ing organisms, represent a promising target to
modulate the bile acid pool and consequently
host physiology.11 However, much remains to be
deciphered about this group of microorganisms,
including their metabolism, diversity, abundance
in the gut, and colonization dynamics in the host.
The spatial organization of the gut microbial com-
munity is suggested to be linked to their function
within the host.12,13 Only one study, conducted by
Midvedt and Norman (1968), has explored the distri-
bution of bile acid-metabolizing bacteria along the
intestinal tract (in this case in rats).14 They pointed
out that the organisms responsible for the elimination
of the 7α-hydroxyl of bile acids are found in the cecum
and feces of rats. Other studies have probed the bile
acid composition longitudinally along the intestinal
tract and observed the formation of deoxycholic acid
(DCA) and lithocholic acid (LCA), the products of 7α-
dehydroxylation of CA and CDCA, respectively,
mainly in the cecum and colon15, suggesting the
large intestine is a colonization site for 7-dehydroxy-
lating bacteria. However, concluding the presence or
absence of certain microorganisms only based on the
in vivo bile acid composition lacks rigor since it does
not link specific organisms with their in vivo activity.
Several studies reported discrepancies in bile acid
transformations by bacteria in vitro or in vivo. For
instance, Narushima et al. (1999), observed that
Clostridium sp. TO-931 (now known as Clostridium
hiranonis16) did not deconjugate tauro-conjugated
bile acids in germ-free mice, although its ability to
deconjugate taurocholic acid (TCA) was shown in -
vitro.17 Furthermore, side chain conjugation of bile
acids precludes 7-dehydroxylation.18 Thus, if the
7-dehydroxylating bacteria does not synthetize bile
salts hydrolases (deconjugating enzymes), they will
rely on deconjugating bacteria to perform 7-dehy-
droxylation. Clostridium hiranonis is a known 7α-
dehydroxylating and deconjugating species, but it
did not perform deconjugation nor 7α-
dehydroxylation in vivo even in the presence of an
additional deconjugating strain (Bacteroides diastonis
K-5).17 Bile acid 7α-dehydroxylation in vivo is likely to
be influenced by various factors including pH, oxygen
partial pressure19, enzymatic co-factors (e.g.,
flavins)20, the bile acid pool, and gut microbes.
Examples of intestinal bacteria influencing bile acid
7α-dehydroxylation include Bacteroides sp. and
a Ruminococcus strain. Bacteroides sp. enhances bile
acid 7α-dehydroxylation by Eubacterium sp. strain
c-25 via an unknown mechanism.21 The
Ruminococcus strain secretes a soluble factor necessary
for the growth of the 7α-dehydroxylating strain
HDCA-1.22 Hence, the production of 7-dehydroxy-
lated secondary bile acid results from complex inter-
actions between the host, the 7-dehydroxylating
species and the gut microbial community.
The model organism used in this study,
Clostridium scindens, is one of the major 7-dehy-
droxylating bacteria found in humans23,24 and
rodents.25 This bacterium was first isolated from
feces of a patient with colon cancer and character-
ized by Holdeman and Moore in 1973.26 Forty-two
years later, C. scindens was identified as a potential
protective gut commensal against Clostridium dif-
ficile infection.7 The 7-dehydroxylated secondary
bile acids (e.g., DCA and LCA) produced by bile
acid 7-dehydroxylating bacteria impact C. difficile
spore germination and outgrowth, thus preventing
the onset of disease.27,28
The objectives of the study are 1) to investigate
the bile acids transformations performed by
Clostridium scindens in vitro, and in vivo in
a gnotobiotic mouse model, and 2) to explore its
colonization dynamics in the murine intestinal
tract using Nanoscale Secondary Ion Mass
Spectrometry (NanoSIMS).29 This study provides
a better understanding of the microbiology of
7-dehydroxylating organisms, and is motivated
by the fact that these commensals constitute
a direct link between bile acids and host health.
Results
Clostridium scindens growth in the presence of
human and murine bile acids in vitro
OD600 measurements were used to quantify the
growth of Clostridium scindens as a function of
time and to assess the impact of primary bile acids
on the growth of this organism (Figure 2(a)). The
primary bile acids CA, UDCA, αMCA and βMCA
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had no significant effect on C. scindens in vitro com-
pared to the control cultures without bile acids. The
biomass was maximal after 24 h of incubation in
media containing CA (ODmax ≈ 1.32 ± 0.015),
UDCA (1.38 ± 0.025), αMCA (1.35 ± 0.015)
and after 28 h of incubation in βMCA medium
(1.43 ± 0.060). In the absence of bile acids (i.e.,
the control), a peak cell density of OD600
= 1.40 ± 0.021 was reached at 24 h of
incubation. Of all the primary bile acids tested,
only CDCA had a significant impact on
C. scindens growth, resulting in a slower growth
rate, a reduced peak cell density and a lower
end point cell density in a dose-dependent
manner. The maximal cell density was reached
after 24 h and 28 h of incubation in the media
containing CDCA 100μM (1.16 ± 0.016) and
CDCA 200μM (1.03 ± 0.023), respectively.
Figure 2. Impact of primary and secondary bile acids on C. scindens growth. C. scindens was grown in BHIS-S medium containing a)
one primary bile acid (CA, CDCA, UDCA, αMCA, βMCA) or b) one secondary bile acid (DCA, 3-oxoDCA, 12-oxoLCA). A control without
bile acids and one sterile control were prepared in parallel. For each bile acid condition or the controls, cultures were prepared in
triplicate. Growth of C. scindens was quantified with OD600 measurements of samples collected from triplicate cultures of C. scindens.
Each symbol indicates the mean and the standard deviation. Statistical analysis used the Holm-Sidak test to compare the maximal
cell density mean of each bile acid condition to the maximal cell density mean of the control without bile acid. The absence of
a symbol under the maximal density time point indicates that there was no statistically significant difference (p > 0.05) relative to
the control group (* = p < 0.05).
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Overall, C. scindens is resistant to most primary
bile acids in vitro. Additionally, we also inves-
tigated the impact of selected secondary bile
acids (DCA, 12-oxoLCA and 3-oxoDCA) on
the growth of C. scindens. These compounds
did not exhibit any evidence of toxicity at
a concentration of 100 µM (Figure 2(b)). Next,
we investigated the bile acid transformations
performed by C. scindens in vitro.
In vitro bile acid transformations by Clostridium
scindens
In order to investigate C. scindens bile acid trans-
formations in vitro, bile acid analyses were per-
formed on the culture supernatants (representing
dissolved BAs (SUP)) and pellets (representing
cell-associated BAs (PEL)). Furthermore, in order
to discriminate between BAs in the cytoplasm
from those bound to the cell envelope, we sepa-
rated the cytoplasmic and cell envelope fraction of
the biomass by ultracentrifugation after cell lysis
for selected pellet samples, and analyzed the bile
acids in both fractions.
We observed that C. scindens removes the C7-
hydroxyl group from CA and CDCA. CA is partially
7α-dehydroxylated to DCA, as reported
previously30, and 12-oxoLCA is also produced
(Figure 3(a)). Overall, about 83% of the CA is con-
verted to 7-dehydroxylated bile acid species (DCA
and 12-oxoLCA) after a 24 h incubation. In contrast,
C. scindens converted only 10% of CDCA to LCA
after 52 h of incubation (Figure 3(d)), presumably
partly due to the toxicity of this compound. The
major 7-dehydroxylated secondary bile acids of CA
include DCA and 12-oxoLCA, and those from
CDCA include LCA and 3-oxoLCA. The 3β-epimer
of LCA (isoLCA) was also detected (Figures 3(d) and
3(e)) but only in a minor amount (< 1μM).
In addition to 7α-dehydroxylation, C. scindens
oxidized hydroxyl groups at the C3 and C7 positions
on CA and CDCA molecules and additionally at the
C12 position for CA (Figure 3). The oxidized sec-
ondary BAs produced include 3-oxoCA,
3-oxoCDCA, 3-oxoLCA, 7-oxoDCA, 7-oxoLCA,
Figure 3. Bile acid transformations by Clostridium scindens in vitro. C. scindens was grown in BHIS-S containing either CA or CDCA in
triplicates. Cultures were sampled and the pellet (PEL) separated from the supernatant (SUP) by centrifugation. Selected pellets were
further fractionated into cytoplasmic and cell envelope fractions. Bile acids quantification is reported for the combined supernatant
and pellet (SUP+ PEL) (a,d), for pellets (PEL) (b,e), and for the cytoplasmic and cell envelope fraction of the biomass (c,f). The
analyses were carried out in triplicate, collected from triplicate cultures of C. scindens. Histograms indicate the mean and one
standard deviation. Time zero represents the minimal amount of time needed to sample the culture, post bacterial amendment.
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and 12-oxoLCA. Some of these secondary bile acid
species, such as 12-oxoLCA (a product of CA trans-
formation) are found in large quantities. 12-oxoLCA
is formed rapidly and abundantly: at 24 h of incuba-
tion, 36% of CA was converted into 12-oxoLCA
(Figure 3(a)). It represents the major cell-associated
bile acid during CA transformation (Figure 3(b))
and is located in the cytoplasmic fraction (Figure 3
(c)). Furthermore, between 24 h and 48 h of incuba-
tion, 12-oxoLCA decreased while DCA concentra-
tions increased (Figure 3(a)).
In studies assessing bile acid transformations
in vitro, the BA mass balance is not always achieved
when measuring solution bile acids.31 Hence, we
quantified BAs in solution as well as associated
with the cells. We found that about 10% and 5% of
the CA- and CDCA-derived secondary bile acids are
cell associated, respectively (Figures 3(b), 3(e)). After
fractionation of the biomass, we observed that LCA
was the only cell-associated BA that was primarily
bound to the cell envelope (Figure 3(f)). C. scindens
ATCC 35704 did not metabolize UDCA nor the two
murine primary bile acids αMCA and βMCA (Figure
S1). In the experiments with CA, UDCA, αMCA and
βMCA (Figure 3(a) and S1), we noticed a decrease in
the total bile acid concentration over time, both in
the experimental and sterile control tubes. This
decrease might be due to the adsorption of bile
acids from the sample to walls of the epitube. In
further experiments, all samples were extracted
with alkaline acetonitrile, circumventing this experi-
mental problem.
The formation of 12-oxoLCA and its accumula-
tion intracellularly was unexpected as it is not an
intermediate of the 7-dehydroxylation pathway32
but rather described as an oxidized form of
DCA.33–36 In contrast, a known intermediate of
the 7-dehydroxylation pathway, 3-oxoDCA, was
not detected in the experiments (Figure 3). In
order to better understand the formation of 12-
oxoLCA, we performed additional in vitro experi-
ments to investigate the transformation products
of DCA, 3-oxoDCA, and 12-oxoLCA (Figure 4).
We observed the oxidation of a small fraction of
DCA (~ 11%) to 12-oxoLCA after 30 min followed
by the reduction of 12-oxoLCA back to DCA
within 36 h (Figure 4(a)). Regarding 3-oxoDCA,
only a small fraction (~ 7%) was converted to
DCA and this transformation was extremely slow
(Figure 4(b)). In contrast, 12-oxoLCA was rapidly
and extensively converted to DCA (Figure 4(c)).
After 6h of incubation, the majority of 12-oxoLCA
(~ 91%) was converted to DCA.
Bile acid 7-dehydroxylation is an intracellular
process. In order to assess whether the limited
transformation of DCA and 3-oxoDCA (Figures 4
(a) and 4(b)) by C. scindens were due to inefficient
transport of these BAs inside the cells, we per-
formed an additional experiment using C. scindens
cell-free extract (CFE) induced with CA before lysis
and exposed to DCA or 3-oxoDCA (Figures 4(d)
and 4(e)). CA is a known inducer of the expression
of the bai operon encoding the 7-dehydroxylating
enzymes.37 The transformation of 12-oxoLCA by
the CA-induced CFE was also assessed (Figure 4
(f)). We observed that the CFE was more efficient at
reducing 3-oxoDCA to DCA as compared to
C. scindens whole cells (Figures 4(b) and 4(e))
despite corresponding to half the cell concentration
(OD600 ~ 0.7 instead of ~ 1.4). The maximal DCA
concentration with CFE was about 35 μM after 10 h
as compared to 5 μM DCA after 60 h incubation
with C. scindens whole cells. Interestingly, we
detected a small fraction (≈ 1.35 ± 0.06 μM after
10 h) of isoDCA, thus demonstrating the potential
of C. scindens to epimerize the C3-hydroxyl group.
Furthermore, another product of transformation of
3-oxoDCA was detected on the chromatogram with
a m/z of 387.2523 [M-H]−, which could correspond
to the elemental composition C24H36O4, so a loss of
two H atoms from 3-oxoDCA. Unfortunately, we
did not have an appropriate standard to definitively
identify and quantify this product based on its
retention time, accurate mass and fragmentation
pattern. This unknown product of 3-oxoDCA
transformation could be 3,12-dioxoDCA, but
further experiments will be needed to confirm this
assignment.
The transformation of DCA by cell-free
extract is similar to that with C. scindens whole
cells. We observed the formation of a maximum
of 13.3 ± 1.5 μM 12-oxoLCA with the CFE
compared to 12.8 ± 1.2 μM with the whole
cells (despite the factor of ~ 2 less protein in
the CFE system). However, the 12-oxoLCA
formed by CFE remained in the medium and
was not reduced back to DCA as observed with
C. scindens whole cells (Figures 4(a) and 4(d)).
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Furthermore, we detected the formation of
a small amount of 3-oxoDCA (3.5 ± 0.1 μM
after 10 h of incubation) with CFE, which was
not observed in the whole cell experiment
(Figures 4(a) and 4(d)).
CFE reduced 12-oxoLCA rapidly and almost
completely to DCA, similarly to our observation
with C. scindens whole cells. In less than 30 min-
utes, almost all 12-oxoLCA (~ 95%) was converted
to DCA (Figure 4(f)).
Clostridium scindens colonization and bile acid
transformation in the murine intestinal tract
In order to investigate BA 7-dehydroxylation by
C. scindens in vivo and its colonization dynamics,
we used 15N and 13C labeled cells of C. scindens.
We calibrated the decrease in δ15N and
δ13C isotopic ratio as a function of division cycle
by growing labeled C. scindens cells in unlabeled
medium and monitoring the change in isotopic
ratio (Figure S2). As expected, the isotopic ratios
(13C/12C and 15N/14N) of individual C. scindens
cells are halved at each cell division as individual
cells undergo symmetric division taking up normal
composition N and C from the medium. Once the
stationary phase is reached and the cells stop
dividing, the isotopic ratios remain quasi constant
(Figure S2). The nitrogen isotopic ratio is 3 times
greater than the carbon ratio and was selected for
further analyses because it affords more resolution
of bacterial division.
The 15N isotopically labeled C. scindens cells were
used to complement the intestinal microbial commu-
nity of mice from a gnotobiotic mouse line
(sDMDMm2) devoid of 7-dehydroxylating
strains.38,39 Six hours after inoculation by gavage of
109 cells, C. scindens was already detectable in the
distal intestinal tract (Figure 5). C. scindens concen-
trations were low in the jejunum and ileum compared
to the large intestine. In the small intestine,C. scindens
numbers were below detection by cultivation at 6 h.
At 24 h, there was on average of 6.5 ± 5.7 x 102 CFU of
C. scindens per g of intestinal content in the ileum
Figure 4. Secondary bile acid transformations by Clostridium scindens in vitro (whole cell and cell-free extract). Transformation
products of the secondary bile acids DCA, 3-oxoDCA and 12-oxoLCA by whole C. scindens cells (WC) (a, b, and c). C. scindens was
grown in BHIS-S containing one secondary bile acid (DCA, 3-oxoDCA, or 12-oxoLCA) in triplicate. Transformation products of the
secondary bile acids DCA, 3-oxoDCA and 12-oxoLCA by CA-induced C. scindens cell-free extract (CFE) (d, e, and f). The synthesis of Bai
enzymes was induced by the amendment of CA to a growing culture of C. scindens. The CA-induced cells were lysed and the cell-free
extracts were amended with DCA, 3-oxoDCA or 12-oxoLCA. Each experiment was carried out in triplicates. Bile acids were extracted
directly from the culture/CFE (supernatant and biomass), representing the total bile acids (‘TOT’). Histograms indicate the mean and
one standard deviation.
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only. In contrast, the cell counts were 6.1 ± 8.6 x 105
and 3.2 ± 4.9 x 105 CFU of C. scindens per g of
intestinal content at 6 h and 24 h, respectively for
the cecum. In the colon, the cell counts were
4.6 ± 6.4 x 106 at 6 h and at 24 h they were comparable
to those in the cecum (7.2 ± 11.5 x. 105)
The nitrogen isotopic ratio of the C. scindens
gavage culture equaled 420,600 (Figure S3).
Thus, within the gut microbial community of
sDMDMm2 mice, C. scindens cells, were readily
detected using the NanoSIMS-generated
12C15N- and 12C13C- images (Figure S4).
The nitrogen isotopic ratio of C. scindens cells
decreased rapidly overtime in the intestinal tract
(Figure 5). After 6 h, the ratios were significantly
lower in the small intestine compared to the large
intestine, suggesting that cells in the large intestine
underwent fewer bacterial divisions than those in
the small intestine. Twenty-four hours after
gavage, the isotopic ratios were lower than at 6 h,
suggesting that cells continued to divide in all
intestinal compartments. There is no statistically
significant difference among the compartments at
24 h indicating that C. scindens cells underwent
a similar number of bacterial divisions. However,
only considering the nitrogen isotope ratios pro-
vides an incomplete view of the process because it
does not take into account the fact that the num-
ber of cells present in the ileum is three orders of
magnitude smaller than that in the cecum or
colon. Hence, while the small number of cells
present in the ileum (and to a lesser extent, the
jejunum) divides at the same rate at those in the
cecum and colon, they represent a small popula-
tion. Thus, the great majority of C. scindens cells
has colonized the large intestine and are dividing
and growing in that compartment.
We analyzed the bile acid profile along the
intestinal tract of sDMDMm2 mice and
sDMDMm2 mice colonized with C. scindens to
explore the impact of C. scindens on the bile acid
metabolome. Figure 6 shows that the luminal bile
acid concentrations vary greatly along the murine
intestinal tract. The bile acid pool in the large
intestine represents about 5% of that in the small
intestine. In the small intestine, the bile acid
Figure 5. Clostridium scindens colonizes the large intestine of the murine gut. C. scindens was grown in vitro in a medium with
15N-labeled nutrients and gavaged into sDMDMm2 mice. A control culture was obtained in a medium lacking labeled compounds
(unlabeled). The nitrogen isotopic ratio of C. scindens along the intestinal tract was quantified from NanoSIMS images. Samples from
two mice (one per time point) were analyzed. C. scindens concentration (CFU/g of intestinal content) were determined by plating on
selective medium. The y-axis indicates 15N isotopic ratio of C. scindens cells. The bubble centers indicate medians and the vertical
bars the interquartile range. The size of the bubbles indicates C. scindens concentrations. Statistical analysis used Mann-Whitney-U
tests to compare the C. scindens isotopic ratios in the small and large intestine. Ns, not statistically significant (p ≥ 0.05),
****p < 0.0001. < LOD implies that the value is below the limit of detection.
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composition is largely accounted for by conjugated
species: TCA, TβMCA, as well as tauro-conjugated
cholic acid sulfated at the C7 position (TCA7S). In
the large intestine, we observe the efficient decon-
jugation of bile acids, with the major remaining
species consisting mainly of sulfated cholic acids
(CA7S and TCA7S) and βMCA.
The presence of these unconjugated bile acids in
the large intestine allows further transformations,
including the epimerization of the hydroxyl group at
the C6 position (producing ωMCA), and the oxida-
tion of the hydroxyl groups at the C3 andC7 positions
(producing 3-oxoCA, 3-oxoCDCA, 7-oxoDCA, and
7-oxoLCA) (Figure 7).18 These transformations occur
in the presence and absence of C. scindens, suggesting
that members of the sDMDMm2 microbial commu-
nity are responsible. Furthermore, the concentrations
of these unconjugated secondary BAs are not signifi-
cantly different in the large intestine of C. scindens-
colonized sDMDMm2 mice relative to control mice
(sDMDMm2) (Figure 7).
There is one bile acid species that is only present in
the mouse with the C. scindens-amended microbiota:
DCA (Figure 8). This is the 7-dehydroxylated form of
CA. This result is consistent with the 7-dehydroxylat-
ing activity of C. scindens and confirms the
Figure 6. Luminal bile acid composition along the intestinal tract of sDMDMm2 mice colonized with C. scindens (sDMDMm2+ Cs)
compared to sDMDMm2 control mice. Bile acids were analyzed with UHPLC-HRMS in four intestinal compartments collected from
sDMDMm2 mice colonized with C. scindens for 24h (n = 3, sDMDMm2+ Cs) and a control group (n = 3, sDMDMm2) that received
a PBS vehicle. The legend indicates the bile acids detected. The ones abundant enough to be visible on the graph are in bold in the
legend. The secondary bile acids are depicted in Figure 7 and 8.
GUT MICROBES 9
Figure 7. Secondary bile acid composition along the intestinal tract of sDMDMm2 mice colonized with C. scindens compared to
control sDMDMm2 mice. Bile acids were analyzed with UHPLC-HRMS in four intestinal compartments collected from sDMDMm2 mice
colonized with C. scindens for 24h (n = 3, sDMDMm2+ Cs) and a control group (n = 3, sDMDMm2) that received PBS vehicle. Statistic
analysis used the Mann-Whitney-U tests to compare the secondary bile acid concentrations in mice colonized with C. scindens to
a control sDMDMm2 mouse. Histograms indicate the mean with the standard deviation. ns, not statistically significant (p ≥ 0.05).
A value of zero indicates that the concentration is below the limit of detection.
Figure 8. Deoxycholic acid (DCA) formation in vivo as a function of time. DCA was quantified with UHPLC-HRMS in four intestinal
compartments (jejunum, ileum, cecum and colon) collected from sDMDMm2 mice colonized with C. scindens for 6h (n = 3,
sDMDMm2+Cs) and 24h (n = 3, sDMDMm2+Cs) and a control group (n = 3, sDMDMm2) that received PBS vehicle. Histograms
indicate the mean with the standard deviation. Mann-Whitney-U tests were performed to compare DCA levels between T6h and T24h.
ns, not statistically significant (p ≥ 0.05). A value of zero indicates that the concentration is below the limit of detection.
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colonization data. The amount of DCA is stable over time in the
cecum and colon (Figure 8).
Discussion
Bile acids exhibit detergent properties. In the small
intestine, they form micelles and promote dietary
lipid solubilization and absorption. When present
at high concentrations, bile acids can be cytotoxic
to the bacteria and the host. The intestinal bile acid
pool (size and composition) is known to structure
the microbial community along the intestinal tract
and therefore plays an important role in maintaining
the intestinal barrier function.40–42
Bile acid 7-dehydroxylating bacteria repre-
sent an important functional group amongst
bile-transforming gut bacteria. They produce
7-dehydroxylated secondary bile acids, which
represent a major fraction of the secondary
bile acids pool (~ 64% in the cecum of the
C. scindens colonized sDMDMm2 mice).
7-dehydroxylated bile acids, such as DCA and
LCA, are potent activators of the bile acid
receptor TGR5, and consequently are involved
in the regulation of glucose homeostasis,
energy expenditure and inflammation.3,4,43 Bile
acid 7-dehydroxylating bacteria thus may
represent a critical link between bile acids and
host health.5 As such, they could be a target for
the prevention and treatment of various meta-
bolic diseases9, as well as Clostridium difficile
infections (CDI)7 and some gastrointestinal
cancers, which are associated with increased
levels of 7-dehydroxylated bile acids.44 Using
7-dehydroxylating bacteria for therapeutic or
preventative applications requires a better
understanding of their microbiology in vivo as
well as their interactions with the host. In the
present study, we explored the bile acid meta-
bolism of C. scindens, a known 7-dehydroxylat-
ing bacterium, both in vitro and in vivo and
investigated its colonization dynamics in the
murine intestinal tract.
The growth of C. scindens ATCC 35704 was
not impacted by the primary or secondary bile
acids tested in vitro (Figures 2(a), 2(b)).
A notable exception is CDCA, which revealed
a toxic effect (Figure 2(a)), as is expected
because it is a hydrophobic bile acid.
C. scindens metabolized CA and CDCA in vitro
and the products of their transformation were
primarily recovered from solution. A notable
exception is LCA, which was associated with the
cell envelope, underscoring its hydrophobicity,
and another is 12-oxoLCA, which was recovered
from the cytoplasm, suggesting it is not effectively
effluxed by the cell (Figure 3). CA was more effi-
ciently dehydroxylated than CDCA (Figure 3(a)),
as was previously reported for C. hiranonis31 and
C. scindens VPI 12708.30
In contrast, the murine primary bile acids αMCA
and βMCA remained unchanged (Figure S1), con-
firming previous reports that human intestinal bac-
teria are unable to metabolize muricholic acids.17,45
A possible explanation for this is host specificity as
C. scindensmay have evolved in the human gut in the
absence of murine primary bile acids. However,
C. scindens may not be an exclusively human com-
mensal as a new strain (strain G10) was recently
isolated from rat feces.25 The 7β-dehydroxylation of
UDCA was also tested in vitro. This transformation
was previously reported for several 7-dehydroxylating
organisms including several C. scindens strains (VPI
12708, 36S, M-18, Y-98, Y-1112, Y-1113) and
Eubacterium strain C-25.31,46 The gene baiI is pre-
dicted to encode a 7β-dehydratase47 but this remains
to be confirmed as this process could also occur via
a 7β-epimerization to CDCA followed by 7α-
dehydroxylation. Here, we did not observe any con-
version of UDCA by C. scindensATCC 35704 in vitro
(Figure S1), consistent with previous reports.48
In vitro, C. scindens also oxidized the C3 and C7
hydroxyl groups in CA and CDCA, yielding 3-oxoCA
and 7-oxoDCA (for CA) and 3-oxoCDCA and
7-oxoLCA (for CDCA) (Figure 3). In addition,
7-dehydroxylation was combined with oxidation, to
produce 12-oxoLCA for CA and 3-oxoLCA for
CDCA, and with epimerization to produce isoLCA.
Oxidation at C3, C7 and C12, as well as 7α- and 7β-
dehydroxylation of the C7 hydroxyl group by various
C. scindens strains have all been previously
reported.23,30–32,46,48,49 Thus, these findings are in
line with the expected composition of the products
of CA and CDCA incubations with C. scindens. In
contrast, it is the first time that epimerization of the
C3-hydroxyl of LCA to isoLCA (3β) is reported for
C. scindens perhaps due to its presence at a low con-
centration (≤ 2μM). While Clostridium scindens
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carries several 3α-hydroxysteroid dehydrogenase (3α-
HSDH) on the bai operon (BaiA enzymes)50, 3β-
HSDHhas never been characterized for this organism.
The BA 7-dehydroxylation pathway invokes the
oxidation of the C3 hydroxyl, followed by the oxida-
tion of the C4-C5 bond, the dehydration at the C7
hydroxyl, the reduction of the C4-C5 and C6-C7
bonds, and finally the reduction of the C3 ketone
group.32 Thus, a 3-oxoDCA intermediate is involved
in the pathway.51 However, we did not detect it in
our experiment (Figure 3) nor is it reported as
a product of CA transformation by C. scindens in
a recent study, while it is detected during CA 7-dehy-
droxylation by C. hiranonis.52 In the same study, no
transformation of 3-oxoDCA into DCA (as would be
expected based on the pathway) is detected in any of
the 7-dehydroxylating strains considered.52
Similarly, our results show thatC. scindens converted
a minor part of 3-oxoDCA (7%) to DCA (Figure 4
(b)). C. scindens has several copies of the baiA gene
encoding 3α-HSDH enzymes50, thus it is unclear
whether the lack of 3-oxoDCA reduction is due to
limited expression of the 3α-HSDHs or to the lack of
transport of 3-oxoDCA into the cell. To circumvent
these possible confounding effects, we used CA-
induced C. scindens CFE to interrogate 3-oxoDCA
transformation. Reduction of 3-oxoDCA ensued
(39% at 10 h), resulting in increased production of
DCA compared to that with whole cells (Figure 4
(e)). These results confirm that 3-oxoDCA is a likely
intermediate in the formation of DCA and that its
intracellular intake is limited.
An unanticipated finding was the transforma-
tion of CA into 12-oxoLCA (Figure 3(a)). This
secondary bile acid has not been reported in pre-
vious CA 7-dehydroxylation experiments with
C. scindens.52 We observed a transient accumula-
tion of this bile acid in the biomass during CA
transformation in vitro (Figure 3(b)). Interestingly,
this bile acid species accumulated in the cytoplasm
of the cells (Figure 3(c)). In the literature, this
secondary bile acid is described as a product of
the oxidation of DCA.33–36,53
We investigated the transformation of 12-
oxoLCA by C. scindens to determine whether 12-
oxoLCA may be reduced to DCA. The transforma-
tion of 12-oxoLCA to DCA by both whole cells and
CFE was very rapid (86% in 2 h and 95% in less than
30 minutes, respectively), suggesting high 12α-
HSDH activity (Figures 4(c) and 4(f)). Similarly,
Doden et al. (2018) report complete conversion of
12-oxoLCA to DCA by the three major 7-dehydrox-
ylating species C. scindens, C. hylemonae and
C. hiranonis.52
In contrast, DCA transformation to 12-oxoLCA
by C. scindens whole cells was slow (11.5% in
30 minutes) and the 12-oxoLCA produced was
converted back to DCA (< 3% remaining at 36 h)
(Figure 4(a)). This is consistent with previous
work by Winter et al. (1984) and Doden et al.
(2018)52 who reported no conversion of DCA by
C. scindens strain ATCC 35704.48 To address the
possible confounding issues of expression of the
12α-HSDH in the presence of DCA and of the
potentially limited uptake of DCA by cells, CA-
induced C. scindens CFE was exposed to DCA and
a minor transformation of DCA to 12-oxoLCA
(11.8% in 12 min) was observed, similar to that
with C. scindens whole cells after 30 minutes.
However, the 12-oxoLCA formed by CFE was
not converted back to DCA over time (Figure 4
(d)). These results suggest that 12-oxoLCA could
be a transient species during CA 7-dehydroxyla-
tion to DCA, which is incompatible with the
7-dehydroxylation pathway.32 Further investiga-
tions are needed to elucidate the occurrence of
this secondary bile acid species, its connection
with the 7-dehydroxylation pathway, and its role
on host physiology.
Overall, the in vitro transformation of CA by
C. scindens involves BA 7-dehydroxylation to
both reduced (DCA and isoDCA) and oxidized
(12-oxoLCA, 3-oxoDCA) secondary BAs as well
as oxidation of primary BAs (7-oxoDCA,
3-oxoCA) (Figure 9). Similarly for CDCA,
reduced (LCA and isoLCA) and oxidized
(3-oxoLCA) 7-dehydroxylated species are formed
along with oxidized primary BAs (7-oxoLCA,
3-oxoCDCA) (Figure 10). The 3-oxo, 7-dehy-
droxylated species (3-oxoDCA and 3-oxoLCA)
are intermediates in the known 7-dehydroxyla-
tion pathway, whereas the 12-oxo, 7-dehydroxy-
lated species (12-oxoLCA) is likely to be
a transient species formed during CA 7-dehy-
droxylation. The 7-oxo species are not substrates
for 7-dehydroxylation32 and require reduction
back to the primary BA for further transforma-
tion by C. scindens (Figures 9 and 10).
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In order to evaluate the relevance of
C. scindens in vitro bile acid transformations
in vivo, we amended a gnotobiotic mouse model
with 15N- and 13C-labeled C. scindens cells and
analyzed the bile acid metabolome along the
intestinal tract. In parallel, we probed the
in vivo colonization behavior of C. scindens by
following the cell isotopic ratios in the mouse
intestine using NanoSIMS. The selected gnoto-
biotic mouse model (sDMDMm2) is associated
with a stable, low-complexity microbiota consist-
ing of 12 species belonging to the main phyla of
the murine gut microbiota and devoid of 7-dehy-
droxylation capability.38 Thus, by amending the
model microbiota with C. scindens, we aimed to
restore bile acid 7-dehydroxylation. This comple-
mented mouse model (sDMDMm2 + C. scindens)
was previously reported by our group.39
However, it is the first time the bile acid profile
along the intestinal tract (jejunum, ileum, cecum
and colon) of this mouse model is documented.
The bile acid composition along the gut in mice
colonized with C. scindens and in the control mouse
confirms previous observations that approximately
95% of the bile acid pool is reabsorbed into the distal
ileum as part of the enterohepatic recirculation and
that only 5% enters the large intestine (Figure 6).54
Additionally, we observe a rapid conversion of CA to
DCA in themice colonized withC. scindens (Figure 8)
while, as expected, DCA is absent in mice that are not
colonized with C. scindens. Hence, the amendment of
C. scindens to the sDMDMm2 mice microbial com-
munity partly restores the expected bile acid composi-
tion by allowing 7α-dehydroxylation, as previously
shown.39 As expected, all the secondary bile acids
detected in vivo (Figures 7 and 8) were not detected
in germ-free mice39, highlighting the role of micro-
organisms in the synthesis of secondary bile acids.
Figure 9. Cholic acid (CA) transformations carried out by Clostridium scindens in vitro and in vivo. The secondary bile acids produced
by C. scindens in vitro are indicated and those that were also detected in vivo are in boxes. The dashed boxes indicate those reported
in vivo in the study from Studer et al. (2016), using the same gnotobiotic mouse model (sDMMDm2 + C. scindens).39 The black arrows
indicate the 7-dehydroxylation pathway and its BA intermediates. The green arrows depict bile acid 7-dehydroxylation and the blue
bidirectional arrows show the oxidation/reduction transformations. Enzymes catalyzing these transformations are indicated next the
arrows. Bai stands for the enzymes of the bai operon involved in the 7-dehydroxylation.
GUT MICROBES 13
Interestingly, in contrast to our observations
in vitro (Figure 3(d)) and the study from Studer
et al. (2016)39, there was no evidence of LCA, sug-
gesting that C. scindens did not 7-dehydroxylate
CDCA in vivo (Figure 6). This discrepancy could
be attributed to the short colonization time with
C. scindens (24 h). Studer et al. (2016) colonized
the mice with C. scindens for 7 days. Similarly, 12-
oxoLCA was reported in the cecum of sDMDMm2
mice colonized with C. scindens for 7 days but not
detected in this study. A longer colonization time
(> 24 h) with C. scindens might be required for the
production of certain secondary bile acids (e.g., LCA
and 12-oxoLCA). Other secondary bile acids formed
from CDCA (e.g., 3-oxoCDCA and 7-oxoLCA) were
detected in the cecum and colon of the mice and
taken together, these secondary bile acids are found
at the same concentration as CDCA, suggesting that
half of the CDCA bile acid pool was oxidized (at C3
and C7). Oxidation of CDCA was also found to
exceed 7-dehydroxylation in vitro (Figure 3(d)).
A possible explanation for this might be that the
enzymes oxidizing bile acids (HSDH) are more
abundantly expressed than the 7-dehydroxylating
enzymes (encoded by bai genes) within the gut
microbial community.55 Further, consistent with
the in vitro data (Figure S1), C. scindens did not use
muricholic acids as substrates for 7-dehydroxylation
in vivo (Figure 6). In contrast to the in vitro data, iso-
secondary bile acids were not detected in the mice.
The concentrations of isoLCA and isoDCA detected
in vitro were low (< 2μM), thus the epimerization of
C3-hydroxyl is a minor transformation of
C. scindens. In humans, other bacteria, such as
Eggerthella lenta and Ruminococcus gnavus, likely
contribute to the formation of iso (3β-hydroxyl)
bile acids which are reported to be the second most
abundant class of bile acids in the gut.56
Figure 10. Chenodeoxycholic acid (CDCA) transformations carried out by Clostridium scindens in vitro and in vivo. The secondary bile
acids produced by C. scindens in vitro are indicated and those that were also detected in vivo are in boxes. The dashed boxes indicate
those reported in vivo in the study from Studer et al. (2016), using the same gnotobiotic mouse model (sDMMDm2 + C. scindens).39
The black arrows indicate the 7-dehydroxylation pathway and its BA intermediates. The green arrows point out the bile acid
7-dehydroxylation and the blue bidirectional arrows show the oxidation/reduction transformations. Enzymes catalyzing these
transformations are indicated next the arrows. Bai stands for the enzymes of the bai operon involved in the 7-dehydroxylation.
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In vivo, we observed that the concentrations of
secondary bile acids (3-oxoCA, 3-oxoCDCA,
7-oxoDCA, 7-oxoLCA and ωMCA) were comparable
between C. scindens-colonized sDMDMm2 mice and
the control sDMDMm2 mice (Figure 7). Thus, in the
large intestine, C. scindens restores bile acid 7-dehy-
droxylation without affecting the rest of the bile acid
pool. In line with this observation, our group recently
reported thatC. scindens association had only aminor
impact on the composition of the sDMDMm2
microbiota.39
To explore the colonization dynamics of this
7-dehydroxylating bacterium in the murine intestinal
tract, mice were inoculated with isotopically labeled
C. scindens cells (with 15N and 13C) and their isotopic
signatures along the gut were measured with
NanoSIMS (Figure S4). As bacteria grow, the N or
C isotopic ratio of C. scindens cells decreases because
C and N with normal isotopic composition is taken
up, diluting the isotopic signature (Figure S2). Thus,
based on the cells isotopic ratios, we can infer the
average number of cell divisions and hence, determine
whether the cells present at that location have grown
relative to previous time point. Given that the cells
were delivered in a single gavage, we surmise that to
remain in the intestinal tract, their growth rate must
exceed the rate of cell death and loss through feces.
Hence, only cells that colonize the intestine should be
able to divide once the bolus has passed through the
intestinal tract (< 6 h). We found that cell growth was
detectable in all compartments, suggesting coloniza-
tion throughout the intestinal tract but cell numbers
were vastly different in the small and large intestines.
In the small intestine,C. scindens numbers were below
detection limit by cultivation at 6 h. At 24 h, there was
about 102-103 CFU of C. scindens per g of intestinal
content in the ileum only. In contrast, the cell counts
ranged between 104-107 CFU of C. scindens per g of
intestinal content at 6 h and 24 h, for the cecum and
colon (Figure 5).
Interestingly, the isotopic ratios of C. scindens cells
were lower in the small intestine than in the large
intestine at 6 h, suggesting that cells underwent more
bacterial divisions in the small than in the large intes-
tine (Figure 5). Thus, there are fewer cells colonizing
the small intestine than the cecum or colon but those
that have colonized appear to divide more rapidly at
the initial time point. Considering the large inoculum
administrated into themice and intestinal motility, we
interpret these results as representing the arrival of
cells from the inoculum (with high isotopic values,
Figure S3) to the large intestine. It is common that
large inocula undergo a ‘lag phase’ in vivo following
administration before colonization starts. The bolus,
dominated by slowly proliferating bacteria, transits
through the gastrointestinal tract and seeds bacteria
that start to genuinely colonize and proliferate. The
bacteria in the small intestine at 6 h arrived a few
hours earlier that those in the large intestine, thus
have undergone more bacterial division and have
lower isotopic ratios. We hypothesize that coloniza-
tion of the small intestine is generally unfavorable but
that there are micro-environments in which the
7-dehydroxylating cells live and divide, particularly
in the ileum. After 24 h, the isotopic ratio is similar
across the entire intestinal tract reflecting the steady-
state colonization of the gut but the overwhelming
majority of the 7-dehydroxylating biomass remains in
the large intestine. This study also demonstrates the
potential of NanoSIMS technology to track
a bacterium of interest in a host.57–59
We demonstrated that C. scindens could divide
in the small intestine and persist in small numbers
(Figure 5). However, the large intestine is its pri-
mary ecological niche, and it is where C. scindens
efficiently performs CA 7-dehydroxylation to DCA
in vivo (Figure 8). DCA was not detected in the
small intestine despite the presence of actively
growing C. scindens 6 h after gavage, based on
NanoSIMS analysis (Figure 5). Several factors
may have impacted bile acid 7-dehydroxylation
in the small intestine. The most parsimonious
explanation is that bile acids in the small intestine
are conjugated (Figure 6), which precludes 7--
dehydroxylation.18 The gnotobiotic sDMDMm2
mice have an efficient deconjugating community
in the large intestine, as most bile acids are decon-
jugated (Figure 6). Thus, C. scindens cells have
access to unconjugated primary BAs that can be
dehydroxylated, which is not the case in the small
intestine.
Interestingly, the majority of the primary BAs in
the cecum and colon are sulfated (76% in C. scindens-
colonized sDMDMm2 mice) while only a small frac-
tion (3% in C. scindens-colonized sDMDMm2 mice)
of the small intestine BAs exhibits this modification
(Figure 6). Bile acid sulfation at the C3 and C7 posi-
tions has been suggested to represent a detoxification
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strategy60 as it effectively increases their solubility,
decreases the intestinal reabsorption and conse-
quently promotes their elimination in feces and
urine.60 However, it has been shown that this mod-
ification precludes 7-dehydroxylation if the sulfate
group is associated with the hydroxyl group at the
C7 position.61
Thus, the colonization dynamics appear to con-
firm the work by Midvedt and Norman (1968)
where they considered the spatial distribution of
the bile acid transformations along the rat intest-
inal tract. Bile acid 7-dehydroxylating bacteria
were found in the cecum but not in the ileum of
three conventional rats.14 Fifty years later, we con-
firm that the bile acid 7-dehydroxylating bacter-
ium C. scindens colonizes primarily the large
intestine of gnotobiotic mice but we also report
limited colonization of the ileum (Figure 5).
However, it is clear that the activity of 7-dehydrox-
ylating bacteria is only detectable in the large
intestine, presumably due to the exclusive avail-
ability of deconjugated bile acids in that intestinal
compartment.
Conclusion
This study provides insight into the microbiology
of 7-dehydroxylating organisms. First, the detailed
analysis of bile acid transformations catalyzed by
C. scindens allowed the uncovering of a novel
intermediate, 12-oxoLCA. It is unclear how this
intermediate fits into the well-established 7-dehy-
droxylation pathway. Further investigations are
required to further unravel the role of this com-
pound in 7-dehydroxylation. Furthermore, we
have shown that DCA and LCA are products of
primary bile acid metabolism by C. scindens (as
expected) but also that other 7-dehydroxylated
species form (e.g., 3-oxoLCA, 12-oxoLCA,
isoDCA and isoLCA) and should be accounted
for in the pool of 7-dehydroxylated product. The
partitioning of bile acids into the cell envelope
occurs for the more hydrophobic species and
should also be considered for bile acid mass bal-
ance purposes. Finally, investigation of the
dynamics of colonization of C. scindens in the
gut using NanoSIMS has confirmed the primarily
cecal and colonic localization of 7-dehydroxylating
bacteria but has also evidenced the colonization of
the ileum by a small number of C. scindens cells.
There is no evidence of bile acid 7-dehydroxyla-
tion in that compartment but growth can clearly
take place fuelled by fermentative processes.
Material and methods
Oligo-MM12 microbiota and gnotobiotic
sDMDMm2 mice
The sDMDMm2 gnotobiotic mouse model was used
in this study. sDMDMm2 mice are colonized with
a mouse-intestine derived 12-species mouse micro-
biota (Oligo-MM12) consisting of the following bac-
terial species: Acutalibacter muris sp. nov. KB18
(DSM 26090), Flavonifractor plautii YL31 (DSM
26117), Clostridium clostridioforme YL32 (DSM
26114), Blautia coccoides YL58 (DSM 26115),
Clostridium innocuum I46 (DSM 26113),
Lactobacillus reuteri I49 (DSM 32035), Enterococcus
faecalis KB1 (DSM 32036), Bacteroides caecimuris sp.
nov. I48 (DSM 26085), Muribaculum intestinale sp.
nov. YL27 (DSM 28989), Bifidobacterium longum
subsp. animalis YL2 (DSM 26074), Turicimonas
muris sp. nov. YL45 (DSM 26109) and
Akkermansia muciniphila YL44 (DSM 26127).
A detailed description of the Oligo-MM12 consor-
tium species and description of novel taxa are pro-
vided by Brugiroux et al., (2016)38 and Lagkouvardos
et al., (2016).62 A group of seven sDMDMm2 mice
(6–12 week old males) was used for the experiment.
Gnotobiotic sDMDMm2 mice (Brugiroux et al.,
2016) were established and maintained at the Clean
Mouse Facility (CMF) of the Department of Clinical
Research of the University of Bern. All animal
experiments were performed in accordance with
the Swiss Federal and the Bernese Cantonal regula-
tions and were approved by the Bernese Cantonal
ethical committee for animal experiments under
license number BE 82/13.
Bacterial strains and culture conditions
Clostridium scindens ATCC 35704 (Morris et al.,
1985)23 was grown in BHIS-S medium, which con-
tains 37g brain heart infusion (BHI), 5 g yeast
extract, 40 mL salts solution (0.2 g CaCl2, 0.2 g
MgSO4, 1 g K2HPO4, 1g KH2PO4, 10g NaHCO3,
and 2g NaCl in 1 L ddH2O), 1g L-cysteine and 2
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g fructose per L ddH2O or on BHIS-S agar (BHIS-
S + 15g/L agar). The in vitro experiments were
conducted in an anaerobic chamber (Coy
Laboratory Products, 95% N2, 5% H2) at 37°C.
For the in vivo experiments, erythromycin (10
μg/mL) was added to BHIS-S agar in order to
select for C. scindens ATCC 35704 from mice
intestinal content samples for quantification pur-
poses. The selective plates (BHIS-S + erythromy-
cin) were incubated in an anaerobic chamber (Don
Whitley A45 HEPA, 10% CO2, 10% H2, 80% N2)
for 72 h at 37°C.
Impact of bile acids on bacterial growth
We assessed the impact of human (CA and
CDCA) and murine (αMCA, βMCA, UDCA)
primary and secondary (3-oxoDCA, 12-
oxoLCA, DCA) bile acids on C. scindens growth
in vitro. Cholic acid (CA, ref. A11257) was pur-
chased from VWR, ursodeoxycholic acid
(UDCA, ref. U5127) from Sigma-Aldrich, che-
nodeoxycholic acid (CDCA, ref. C0940-000),
alpha-muricholic acid (αMCA, ref. C1890-000),
beta-muricholic acid (βMCA, ref. C1895-000),
deoxycholic acid (DCA, ref. C1070-000), 3-oxo-
deoxycholic acid (3-oxoDCA, ref. C1725-000)
and 12-oxolithocholic acid (12-oxoLCA, ref.
C1650-000) from Steraloids. These bile acids
were dissolved in 100% ethanol and then,
added to Erlenmeyer flasks with autoclaved and
anoxic 150mL BHIS-S liquid medium (final con-
centration of ethanol in the medium ≤ 1%) to
a final concentration of 100 μM. The concentra-
tion of 100 μM was chosen based on other
studies investigating bile acid transformations
in vitro but also to ensure the detection of
minor transformation products.31,49 An addi-
tional condition (CDCA at a concentration of
200 μM) was included as this concentration
was also used for the bile acid transformation
experiments in vitro. A control without bile acid
(but with the ethanol vehicle) and a sterile con-
trol were prepared in parallel. For each bile acid
condition or the controls, cultures were prepared
in triplicate. Samples were taken regularly and
OD600 was immediately measured with a V-1200
spectrophotometer (VWR).
Bile acid transformations experiments
Bile acid containing media and the controls (with-
out bile acid) were inoculated with C. scindens to
an initial OD600 value of 0.050. Bile acids were
probed at a concentration of 100 µM albeit a higher
concentration was used for CDCA (200 μM)
because of the low conversion to LCA and the
attendant detection issues. This experiment was
done in triplicates. A sterile control and an addi-
tional control without bile acid (but with the etha-
nol vehicle) were prepared in triplicates.
The tubes were incubated in an anaerobic
chamber (Coy Laboratory Products, 95% N2, 5%
H2) at 37°C. Samples were collected periodically
and OD600 was measured immediately after sam-
pling. Each sample (1 mL) was centrifuged at 4°C
for 5 minutes at 16,000 x g. The supernatant (SUP)
was separated from the pellet (PEL) and placed in
a new epitube. For experiments with DCA, 12-
oxoLCA and 3-oxoDCA, an additional 1 mL of
culture was collected. This sample containing both
supernatant and biomass was named ‘Total’
(TOT). Samples (pellets, supernatants, total) were
stored at −20°C to await bile acid analysis.
An additional experiment was conducted on
a few PEL samples to determine whether the bile
acids present in the pellet (biomass) are located
intracellularly (in the cytoplasm) or are bound to
the cell envelope. The selected pellets (CA t = 68 h,
CDCA t = 44 h) were re-suspended in sterile water
containing lysozyme (1 mg/mL) and incubated for
1 h at 37°C. After cell lysis, samples were ultra-
centrifuged (20,000 x g) at 4°C, for 30 min. The
supernatant (corresponding to the cytoplasmic
fraction) was collected in another epitube. The
pellet (representing the cell envelope fraction)
was also retained. All samples were stored at
−20°C to await bile acid analysis.
Cell-free extract (CFE) experiment
This experiment was designed to test whether the
lack of intracellular transport of bile acids was
responsible for the limited transformation of
3-oxoDCA and DCA by C. scindens. As a positive
control, we also included 12-oxoLCA. This experi-
ment was performed under anaerobic conditions, as
bile acid 7-dehydroxylation is sensitive to oxygen.19
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C. scindens was grown in BHIS-S medium. When
bacterial growth reached mid-exponential phase
(OD600 = 0.7), CA was added to the culture to
a final concentration of 100 μM, in order to induce
the synthesis of bile acid inducible (bai) enzymes.
After 90 min of incubation with CA, the culture was
centrifuged and the supernatant (containing CA)
removed. The pellets of C. scindens cells were re-
suspended in BHIS-S containing 2 mg/mL lysozyme
and incubated at 37°C for 90 min. After cell lysis,
3-oxoDCA, DCA, or 12-oxoLCA were added sepa-
rately to themedium (Cf = 100 μM). This experiment
was done in triplicates and sampled were collected
every 2 h during 10 h. Samples were stored at −20°C
to await bile acid analysis.
Preparation of standard solutions
Stock solutions [10 mM] of each internal and exter-
nal BA standard were prepared in methanol.
Deuterated LCA, DCA, CDCA, CA, TUDCA and
TCA (Table S2) were used as internal standards
(ISTD). Individual standard solutions [100 µM]
were mixed together and diluted with ammonium
acetate [5 mM] – methanol (50:50, v/v) to construct
external standard curves between 1 and 10,000 nM.
Each calibration level was spiked with the mixed
ISTD solution [4 µM] for a final concentration of
500 nM. Additionally, 50 µL of BHIS-S medium was
added to each calibration level of the standard curves
used for quantification of in vitro supernatant sam-
ples (SUP) to account for matrix effects.
Bile acid extraction from cell cultures
Supernatants (SUP) from in vitro experiments were
spiked with the mixed ISTD solution [4 µM] and
diluted with ammonium acetate [5 mM] – methanol
(50:50, v/v) to obtain the same final concentration of
ISTD [500 nM].
BAs contained in pellets (PEL), in total (TOT) and
cell-free extract (CFE) samples were extracted with
the following protocol. Freeze-dried samples were
first spiked with 100 µL of mixed ISTD solution
[100 µM] and then extracted with 500 µL of ice-
cold alkaline acetonitrile in 2 mL tubes filled with
0.5 mm glass beads using an automated Precellys 24
Tissue Homogenizer (Bertin Instruments) at
6,500 rpm for 3 × 30 s with a 30 s break. Samples
were vigorously vortexed, and continuously shaken
for 1 h at room temperature. The mixtures were
centrifuged at 16,000 x g for 10 min and the super-
natants collected and lyophilized in a rotational
vacuum concentrator (Christ) before reconstitution
in 1 mL of ammonium acetate [5mM] – methanol
(50:50, v/v) pH 6. The reconstituted samples were
further diluted 20 times in the same solution prior to
LC-MS injection.
Isotopic labeling of C. scindens cells
C. scindens was serially grown (≥ 50 generations) in
medium composed of a 9:1 ratio of Celtone
Complete Medium (CCM – 13C, 98%+, 15N, 98%+)
to BHIS-S1/2 medium. BHIS-S1/2 corresponds to
a 1:1 mixtureof BHIS-S medium and sterile
ddH2O amended with 5 g/L of Celtone Base
Powder (CBP – 13C, 98%+, 15N, 98%+). C. scindens
did not grow in the CCM alone and required the
amendment of a small volume of BHIS-S1/2. The
final labeled medium contained only a small amount
of unlabeled nutrients (coming from BHIS-S).
An unlabeled culture of C. scindens (control)
was prepared following the same protocol but
with unlabeled CCM and unlabeled CBP. Labeled
CCM (ref. CGM-1040-CN-0.1) and CBP (ref.
CGM-1030P-CN-PK), as well as unlabeled CCM
(ref. CGM-1040-U-0.1) and CBP (ref. CGM-
1030P-U-PK) were purchased from Cambridge
Isotope Laboratories.
In vitro experiment: dilution of C. scindens
isotopic labeling in unlabeled medium
C. scindens was labeled in vitro according to the
procedure described above. The labeled cells were
transferred into BHIS-S medium (lacking labeled
nutrient) and incubated anaerobically at 37°C for
24 h while sampling periodically. Growth was
quantified using OD600 measurement. All the sam-
ples were fixed in 2.5% glutaraldehyde and rinsed
at least three times with sterile ddH2O. Samples
were stored at 4°C to await NanoSIMS analysis.
Animal experiment
Cultures of isotopically labeled and unlabeled (con-
trol) C. scindens were centrifuged and washed in
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PBS-1X prior to mouse gavage. A total of seven
sDMDMm2 mice were included in our study. Four
mice were inoculated with 109 labeled C. scindens
cells (L-mice) and two mice with 109 unlabeled
C. scindens cells (U-mice). A sample of the inoculum
was kept for NanoSIMS analysis. One additional
mouse was used as a control and was gavaged only
with PBS-1X. Only for bile acid analysis, two addi-
tional control mice were included in the study to
have an equal number of mice in the two groups
compared (Figures 6, 7 and 8). Six and twenty-four
hours after inoculation, 2 ‘L-mice’ and 1 ‘U-mice’
were sacrificed. The control mouse was sacrificed at
the end of the experiment (t24h). The content of four
intestinal compartments were collected: two parts of
the small intestine (jejunum and ileum), the cecum
and the colon. For each sample, the intestinal con-
tent was divided into 3 tubes for the different ana-
lyses. The samples for NanoSIMS (intestinal
contents samples and C. scindens inoculum) were
fixed with 2.5% glutaraldehyde (for a minimum of
3 h). The fixed samples were rinsed (at least 3 times)
with sterile ddH2O and stored at 4°C to await
NanoSIMS analysis. The samples for bile acid analy-
sis were stored at −20°C. The samples for C. scindens
quantification were directly plated on a selective
medium (BHIS-S + erythromycin) and incubated
in an anoxic chamber at 37° for 72 h. In the results
part, C. scindens counts are expressed as colony-
forming unit (CFU) per gram of fecal content. The
values indicated in the paper represent the mean
± standard deviation.
Nanosims sample preparation and analysis
Two types of samples were analyzed by NanoSIMS:
the in vitro samples (C. scindens culture), and the
in vivo samples (mouse intestinal contents).
Regarding the in vivo experiment, samples of one
L-mouse per time point were chosen for the analysis.
The fixed samples (from the in vitro and in vivo
experiments) were mounted on silicon wafers: for
each sample, 5 to 10 μL of bacterial suspension was
deposited in the center of the silicon wafers and
dried at 37°C. The silicon wafers were then coated
with 10 nm of gold to avoid charging effects. The
distribution of the secondary ions species 12C15N−,
12C14N−, 12C13C−, and 12C12C− on bacterial cells
was mapped with a NanoSIMS 50L (Cameca)
operating at a mass resolution of > 9000 (Cameca
definition), sufficient to resolve these masses from
potential mass interferences. Images of typically
30x30μm2 with a resolution of 256 × 256 pixels
and a primary beam diameter of about 120 nm
were collected across the samples. Each NanoSIMS
image consists of 5 sequential images that were
drift corrected, and accumulated using the soft-
ware L’IMAGE (developed by Dr. Larry Nittler,
Carnegie Institution of Washington, USA).
Nitrogen and carbon isotopes ratio images were
obtained by taking the ratio between the cumu-
lated 12C15N−, 12C14N− and 12C13C−, 12C12C−
images, and reported in the delta notation against
a control sample of normal isotopic composition
measured several times during the same run:
Rðin ‰Þ ¼ R SampleRControl 1
 
 1000, where R
represents either 15N/14N or 13C/12C, respectively.
Regions of interest (ROIs) were drawn around
single C. scindens cells or small cluster of cells with
the software L’IMAGE to quantify mean
δ15N enrichments of the C. scindens cells along
the intestinal tract or in BHIS-S medium (for the
in vitro experiment).
Bile acid extraction from intestinal content
Approximately 10 milligrams of freeze-dried intest-
inal contents were homogenized with 200 µL of ISTD
solution ([1mMor 25μM] depending on the intestinal
compartment) in 2 mL tubes filled with 2.8 mm zir-
conium oxide beads. Homogenization was performed
using an automated Precellys 24 Tissue Homogenizer
(Bertin Instruments) at 5000 rpm for 1 × 20 s. Mixed
samples were equilibrated on ice for 1 h. An amount
of 500 µL of ice-cold alkaline acetonitrile (5% ammo-
nia in acetonitrile) was added to the homogenates,
which were then vigorously vortexed, and continu-
ously shaken for 1 h at room temperature. The mix-
tures were centrifuged at 16,000 x g for 10min and the
supernatants collected. The pellets were extracted
with another 500 µL of ice-cold alkaline acetonitrile.
Supernatants from the two extractions steps were
pooled and lyophilized in a rotational vacuum con-
centrator (Christ) before reconstitution in 100 µL of
ammonium acetate (5 mM) – methanol (50:50, v/v)
pH 6 and stored at −20°C. Supernatants were diluted
according to the intestinal compartment (4000 times
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for the small intestine samples and 100 times for the
cecum and colon samples) for LC-MS injection.
UHPLC-HRMS analyses
Both qualitative and quantitative analyses were con-
ducted on an Agilent 6530 Accurate-Mass Q-TOF
LC/MS mass spectrometer coupled to an Agilent
1290 series UHPLC system (Agilent Technologies).
The separation was achieved using a Zorbax Eclipse-
Plus C18 column (2.1 × 100 mm, 1.8 µm; Agilent
Technologies) heated at 50°C. A binary gradient
system consisted of ammonium acetate [5 mM] pH
6 in water as eluent A and acetonitrile as eluent
B. The sample separation was carried out at
0.4 mL/min over a 22 min total run time using the
following program: 0–5.5 min, isocratic 21.5% B;
5.5–6 min, 21.5–24.5% B; 6–10 min, 24.5–25% B;
10–10.5 min, 25–29% B; 10.5–14.5 min, isocratic
29% B; 14.5–15 min, 29–40% B; 15–18 min,
40–45% B; 18–20.5 min, 45–95% B, 20.5–22 min,
isocratic 95%. The system was re-equilibrated in
initial conditions for 3 min. The sample manager
system temperature was maintained at 4°C and the
injection volume was 5 µL. Mass spectrometer detec-
tion was operated in negative ionization mode using
the Dual AJS Jet stream ESI Assembly. The QTOF
instrument was operated in 4 GHz high-resolution
mode (typical resolution 17,000 (FWHM) at m/z
1000) in profile mode and calibrated in negative
full scan mode using ESI-L solution (Agilent
Technologies). Internal calibration was performed
during acquisition via continuous infusion of
a reference mass solution [5 mM purine, 1 mM
HP-921 (Agilent reference mass kit, Agilent
Technologies) in 95% MeOH acidified with 0.1%
formic acid] and allowed to permanently achieve
a mass accuracy better than 5 ppm. HR mass spectra
were acquired over the range of m/z 100–1700 at an
acquisition rate of 5 spectra/s. AJS settings were as
follows: drying gas flow, 8 L/min; drying gas tem-
perature, 300°C; nebulizer pressure, 35 psi; capillary
voltage, 3500 V; nozzle voltage, 1000 V; fragmentor
voltage, 175 V; skimmer voltage, 65 V; octopole 1 RF
voltage, 750 V. Data were processed using the
MassHunter Workstation (Agilent Technologies).
According to this method, 40 bile acids (SI Table 2)
were quantified by external calibration curves and
corrected with internal standards. Extracted ions
chromatograms (EIC) were based on a retention
time (RT) window of ± 0.5 min with a mass-
extraction-windows (MEW) of ± 30 ppm centered
on m/ztheor of each bile acid. For each BA, the limits
of detection (LODs) were estimated by using the
signal-to-noise ratio (S/N) equal to or over 3, values
calculated automatically by the program after injec-
tion of serially diluted calibration standard solutions
(Table S2).
Statistical analysis
All statistical analyses were performed using
GraphPad Prism 7 software (GraphPad Software).
The statistical tests used are indicated in the figure
legends. P values < 0.05 were considered statisti-
cally significant.
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